CompletedNCT01555346

Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies

Studying Down syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sequenom, Inc.
Principal Investigator
Juan-Sebastian Saldivar, MD
Sequenom Laboratories
Enrollment
3062 enrolled
Eligibility
18-60 years · FEMALE
Timeline
20122015

Study locations (29)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01555346 on ClinicalTrials.gov

Other trials for Down syndrome

Additional recruiting or active studies for the same condition.

See all trials for Down syndrome

← Back to all trials